Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02046187

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Phase I/II Prospective Trial for Newly Diagnosed GBM, With Upfront Gross or Subtotal Resection, Followed by Ketogenic Diet With Radiotherapy and Concurrent Temodar(R) Chemotherapy Followed by Adjuvant Temodar(R) Chemotherapy.

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Conditions Glioblastoma (GBM)

Interventions Ketogenic Diet Radiation therapy Temozolomide

Updated 8 times since 2017 Last updated: Jun 11, 2021 Started: Oct 31, 2013 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

excessive protocol deviations due to strict nature of diet requirements

Other terminated trials from St. Joseph's Hospital and Medical Center, Phoenix

See all terminations from St. Joseph's Hospital and Medical Center, Phoenix

A PHASE1/PHASE2 clinical study on Glioblastoma (GBM), this trial is terminated or withdrawn. The trial is conducted by St. Joseph's Hospital and Medical Center, Phoenix and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Sep 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jan 2021 — Sep 2021 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2

▶ Show 3 earlier versions

Sep 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

Status: Active Not Recruiting → Terminated
May 2017 — Sep 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2
Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Joseph's Hospital and Medical Center, Phoenix

Data source: St. Joseph's Hospital and Medical Center, Phoenix

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States